Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-050621

Options or other derivatives

  • President and CEO acquired 1,445,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Basta Steven L President and CEO 2025-04-03 Grant or award · Performance Shares +360,000 360,000 D
Basta Steven L President and CEO 2025-04-03 Grant or award · Stock Option (Right to Buy) +1,085,000 1,085,000 D
Loading xslF345X05/ownership.xml…